489 related articles for article (PubMed ID: 10866664)
1. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription.
Zhou M; Halanski MA; Radonovich MF; Kashanchi F; Peng J; Price DH; Brady JN
Mol Cell Biol; 2000 Jul; 20(14):5077-86. PubMed ID: 10866664
[TBL] [Abstract][Full Text] [Related]
2. Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation.
Isel C; Karn J
J Mol Biol; 1999 Jul; 290(5):929-41. PubMed ID: 10438593
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 Tat-associated RNA polymerase C-terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat-mediated transcription.
Nekhai S; Zhou M; Fernandez A; Lane WS; Lamb NJ; Brady J; Kumar A
Biochem J; 2002 Jun; 364(Pt 3):649-57. PubMed ID: 12049628
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation.
Kim YK; Bourgeois CF; Isel C; Churcher MJ; Karn J
Mol Cell Biol; 2002 Jul; 22(13):4622-37. PubMed ID: 12052871
[TBL] [Abstract][Full Text] [Related]
5. TFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription.
Zhou M; Nekhai S; Bharucha DC; Kumar A; Ge H; Price DH; Egly JM; Brady JN
J Biol Chem; 2001 Nov; 276(48):44633-40. PubMed ID: 11572868
[TBL] [Abstract][Full Text] [Related]
6. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.
Garber ME; Mayall TP; Suess EM; Meisenhelder J; Thompson NE; Jones KA
Mol Cell Biol; 2000 Sep; 20(18):6958-69. PubMed ID: 10958691
[TBL] [Abstract][Full Text] [Related]
7. Human and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate.
Ramanathan Y; Reza SM; Young TM; Mathews MB; Pe'ery T
J Virol; 1999 Jul; 73(7):5448-58. PubMed ID: 10364292
[TBL] [Abstract][Full Text] [Related]
8. Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences.
Bourgeois CF; Kim YK; Churcher MJ; West MJ; Karn J
Mol Cell Biol; 2002 Feb; 22(4):1079-93. PubMed ID: 11809800
[TBL] [Abstract][Full Text] [Related]
9. Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase.
Chen D; Zhou Q
Mol Cell Biol; 1999 Apr; 19(4):2863-71. PubMed ID: 10082552
[TBL] [Abstract][Full Text] [Related]
10. The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat.
Fujinaga K; Cujec TP; Peng J; Garriga J; Price DH; Graña X; Peterlin BM
J Virol; 1998 Sep; 72(9):7154-9. PubMed ID: 9696809
[TBL] [Abstract][Full Text] [Related]
11. A human primary T-lymphocyte-derived human immunodeficiency virus type 1 Tat-associated kinase phosphorylates the C-terminal domain of RNA polymerase II and induces CAK activity.
Nekhai S; Shukla RR; Kumar A
J Virol; 1997 Oct; 71(10):7436-41. PubMed ID: 9311822
[TBL] [Abstract][Full Text] [Related]
12. The Tat/TAR-dependent phosphorylation of RNA polymerase II C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNA.
Zhou M; Deng L; Kashanchi F; Brady JN; Shatkin AJ; Kumar A
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12666-71. PubMed ID: 14569024
[TBL] [Abstract][Full Text] [Related]
13. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
[TBL] [Abstract][Full Text] [Related]
14. Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription.
Zhou M; Deng L; Lacoste V; Park HU; Pumfery A; Kashanchi F; Brady JN; Kumar A
J Virol; 2004 Dec; 78(24):13522-33. PubMed ID: 15564463
[TBL] [Abstract][Full Text] [Related]
15. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription.
O'Keeffe B; Fong Y; Chen D; Zhou S; Zhou Q
J Biol Chem; 2000 Jan; 275(1):279-87. PubMed ID: 10617616
[TBL] [Abstract][Full Text] [Related]
16. Relief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter.
Fong YW; Zhou Q
Mol Cell Biol; 2000 Aug; 20(16):5897-907. PubMed ID: 10913173
[TBL] [Abstract][Full Text] [Related]
17. Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription.
García-Martínez LF; Mavankal G; Neveu JM; Lane WS; Ivanov D; Gaynor RB
EMBO J; 1997 May; 16(10):2836-50. PubMed ID: 9184228
[TBL] [Abstract][Full Text] [Related]
18. DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation.
Ping YH; Rana TM
J Biol Chem; 2001 Apr; 276(16):12951-8. PubMed ID: 11112772
[TBL] [Abstract][Full Text] [Related]
19. Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression.
Fujinaga K; Irwin D; Geyer M; Peterlin BM
J Virol; 2002 Nov; 76(21):10873-81. PubMed ID: 12368330
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter.
Deng L; Ammosova T; Pumfery A; Kashanchi F; Nekhai S
J Biol Chem; 2002 Sep; 277(37):33922-9. PubMed ID: 12114499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
